Christensen Molecular Epidemiology Lab

Principal Investigator

Brock C. Christensen, Ph.D.

Professor of Epidemiology and of Molecular and Systems Biology

Co-Director, Cancer Population Sciences Research Program | NCCC

Dr. Christensen received his B.S. from the University of Wisconsin Madison in Medical Microbiology & Immunology and French, and his Ph.D. from Harvard University in Biological Sciences in Public Health. He trained as a postdoctoral research associate in molecular epidemiology of cancer at Brown University in the Department of Pathology and Laboratory Medicine. Dr. Christensen joined the faculty at Dartmouth in 2011.

February 2022

Dr. Lucas Salas M.D., MPH, Ph.D., and QBS Ph.D. student Ze Zhang, published their novel immune-profiling method using DNA from blood in Nature Communications. Their work is picked up by the online news services GenomeWeb and Medical Xpress.

Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling

September 2021

Graduating Geisel School of Medicine M.D., Dr. Nasim Azizgolshani, published her lead author work on pediatric central nervous system tumor epigenetic profiles in Clinical Epigenetics.

DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker

January 2021

New NCI R01 grant that aims to predict response to immunotherapy in patients with head and neck cancers. Includes collaborators at Brown, Dana-Farber Cancer Institute, University of Kansas, and Dartmouth Hitchcock.

NIH RePORTER: DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy